EUVIMEDEUVIMED entdecken
Crossref

HOXC 6 Activates BCAT 1 Expression to Promote Oral Cancer Development

Meiheriban Tuerhong, Zaynure Wubulihasimu, Bo Xu, Ling Zhang iD

Oral Diseases · 2025

DOI: 10.1111/odi.70049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oral Diseases, 2025. Verfasst von Meiheriban Tuerhong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Second People's Hospital of Kashi Prefecture, Kashi, Xinjiang, P.R. China. Hauptthemen laut MEDLINE: Mouth Neoplasms, Homeodomain Proteins. Die Arbeit nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

This paper aims to reveal the impact of HOXC6 on oral cancer development through the regulation of BCAT1 and the molecular mechanism.

Methods

BCAT1 expression in oral cancer tissues and adjacent tissues was verified by western blot analysis and RT‐qPCR. After knocking down BCAT1, the HN6 and HN30 cell proliferation, migration, invasion, and apoptosis were detected. The upstream mechanism of BCAT1 elevation was investigated by bioinformatics analysis. HOXC6 expression was detected by immunohistochemistry in oral cancer and adjacent tissues. ChIP and dual‐luciferase assay were used to detect the interaction between HOXC6 and the BCAT1 promoter. Rescue experiments were carried out to substantiate the malignant phenotype and epithelial‐to‐mesenchymal transition (EMT) of oral cancer cells. An in vivo xenograft tumor model was constructed.

Results

BCAT1 and HOXC6 were abnormally high in oral cancer tissues. Inhibition of BCAT1 suppressed the proliferation, migration, invasion, and EMT, and promoted apoptosis of oral cancer cells. HOXC6 downregulation curbed the malignant behavior and EMT program of oral cancer cells. HOXC6 was enriched in the BCAT1 promoter in oral cancer cells. HOXC6 silencing downregulated BCAT1 expression. Transcriptional activation of BCAT1 by HOXC6 promoted oral cancer progression.

Conclusion

HOXC6 knockdown inhibits BCAT1 expression to suppress oral cancer development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mouth NeoplasmsHomeodomain ProteinsHumansEpithelial-Mesenchymal TransitionCell ProliferationApoptosisCell MovementAnimalsCell Line, TumorGene Expression Regulation, NeoplasticPromoter Regions, GeneticNeoplasm InvasivenessMiceMaleMice, Nude

Stichwörter der Autor:innen

BCAT1HOXC6apoptosisepithelial‐to‐mesenchymal transitionoral cancer

Substanzen

Homeodomain ProteinsHOXC6 protein, human

Autor:innen und Institutionen

  • Department of Oral and Maxillofacial Surgery, Second People's Hospital of Kashi Prefecture, Kashi, Xinjiang, P.R. China.
  • Department of Oral and Maxillofacial-Head and Neck Oncology, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, P.R. China.

ORCID-Profile: Ling Zhang

Zitieren

APA

Tuerhong, M., Wubulihasimu, Z., Xu, B., & Zhang, L. (2025). HOXC 6 Activates BCAT 1 Expression to Promote Oral Cancer Development. Oral Diseases. https://doi.org/10.1111/odi.70049

Vancouver

Tuerhong M, Wubulihasimu Z, Xu B, Zhang L. HOXC 6 Activates BCAT 1 Expression to Promote Oral Cancer Development. Oral Diseases. 2025. doi:10.1111/odi.70049

BibTeX
@article{Tuerhong2025,
  author = {Tuerhong, Meiheriban and Wubulihasimu, Zaynure and Xu, Bo and Zhang, Ling},
  title = {HOXC 6 Activates BCAT 1 Expression to Promote Oral Cancer Development},
  journal = {Oral Diseases},
  year = {2025},
  doi = {10.1111/odi.70049}
}
Kostenlos starten →